Alta Partners Viii, L.p. - Net Worth and Insider Trading

Alta Partners Viii, L.p. Net Worth

The estimated net worth of Alta Partners Viii, L.p. is at least $260 Million dollars as of 2024-11-10. Alta Partners Viii, L.p. is the 10% Owner of ZS Pharma Inc and owns about 2,646,643 shares of ZS Pharma Inc (ZSPH) stock worth over $238 Million. Alta Partners Viii, L.p. is the 10% Owner of Allakos Inc and owns about 11,519,200 shares of Allakos Inc (ALLK) stock worth over $16 Million. Alta Partners Viii, L.p. is also the 10% Owner of Esperion Therapeutics Inc and owns about 2,552,189 shares of Esperion Therapeutics Inc (ESPR) stock worth over $6 Million. Details can be seen in Alta Partners Viii, L.p.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alta Partners Viii, L.p. has not made any transactions after 2018-07-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Alta Partners Viii, L.p.

To

Alta Partners Viii, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Alta Partners Viii, L.p. owns 9 companies in total, including Allakos Inc (ALLK) , Sutro Biopharma Inc (STRO) , and Evofem Biosciences Inc (EVFM) among others .

Click here to see the complete history of Alta Partners Viii, L.p.’s form 4 insider trades.

Insider Ownership Summary of Alta Partners Viii, L.p.

Ticker Comapny Transaction Date Type of Owner
ALLK Allakos Inc 2018-07-23 10 percent owner
STRO Sutro Biopharma Inc 2018-09-26 10 percent owner
EVFM Evofem Biosciences Inc 2014-11-19 10 percent owner
LIMIT LIMIT 2015-06-08 10 percent owner
LIMIT LIMIT 2015-05-06 10 percent owner
LIMIT LIMIT 2014-10-21 10 percent owner
LIMIT LIMIT 2014-01-30 10 percent owner
LIMIT LIMIT 2014-03-26 10 percent owner
LIMIT LIMIT 2014-07-29 10 percent owner

Alta Partners Viii, L.p. Latest Holdings Summary

Alta Partners Viii, L.p. currently owns a total of 3 stocks. Among these stocks, Alta Partners Viii, L.p. owns 2,646,643 shares of ZS Pharma Inc (ZSPH) as of June 8, 2015, with a value of $238 Million and a weighting of 91.77%. Alta Partners Viii, L.p. owns 11,519,200 shares of Allakos Inc (ALLK) as of July 23, 2018, with a value of $16 Million and a weighting of 5.99%. Alta Partners Viii, L.p. also owns 2,552,189 shares of Esperion Therapeutics Inc (ESPR) as of October 21, 2014, with a value of $6 Million and a weighting of 2.24%.

Latest Holdings of Alta Partners Viii, L.p.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ZSPH ZS Pharma Inc 2015-06-08 2,646,643 89.98 238,144,937
ALLK Allakos Inc 2018-07-23 11,519,200 1.35 15,550,920
ESPR Esperion Therapeutics Inc 2014-10-21 2,552,189 2.28 5,806,230

Holding Weightings of Alta Partners Viii, L.p.


Alta Partners Viii, L.p. Form 4 Trading Tracker

According to the SEC Form 4 filings, Alta Partners Viii, L.p. has made a total of 0 transactions in ZS Pharma Inc (ZSPH) over the past 5 years. The most-recent trade in ZS Pharma Inc is the sale of 175,427 shares on June 8, 2015, which brought Alta Partners Viii, L.p. around $10 Million.

According to the SEC Form 4 filings, Alta Partners Viii, L.p. has made a total of 0 transactions in Allakos Inc (ALLK) over the past 5 years. The most-recent trade in Allakos Inc is the acquisition of 250,000 shares on July 23, 2018, which cost Alta Partners Viii, L.p. around $5 Million.

According to the SEC Form 4 filings, Alta Partners Viii, L.p. has made a total of 0 transactions in Esperion Therapeutics Inc (ESPR) over the past 5 years. The most-recent trade in Esperion Therapeutics Inc is the acquisition of 500,000 shares on October 21, 2014, which cost Alta Partners Viii, L.p. around $10 Million.

Insider Trading History of Alta Partners Viii, L.p.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Alta Partners Viii, L.p. Trading Performance

GuruFocus tracks the stock performance after each of Alta Partners Viii, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Alta Partners Viii, L.p. is 53.74%. GuruFocus also compares Alta Partners Viii, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Alta Partners Viii, L.p. within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Alta Partners Viii, L.p.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Alta Partners Viii, L.p.

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 21.48 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 16.89 LIMIT LIMIT LIMIT LIMIT LIMIT

Alta Partners Viii, L.p. Ownership Network

Ownership Network List of Alta Partners Viii, L.p.

No Data

Ownership Network Relation of Alta Partners Viii, L.p.

Insider Network Chart

Alta Partners Viii, L.p. Owned Company Details

What does Allakos Inc do?

Who are the key executives at Allakos Inc?

Alta Partners Viii, L.p. is the 10 percent owner of Allakos Inc. Other key executives at Allakos Inc include Chief Financial Officer Harlan Baird Radford , Chief Medical Officer Craig A. Paterson , and General Counsel and Secretary Margaret Nell Fitzgerald .

Allakos Inc (ALLK) Insider Trades Summary

Over the past 18 months, Alta Partners Viii, L.p. made no insider transaction in Allakos Inc (ALLK). Other recent insider transactions involving Allakos Inc (ALLK) include a net sale of 87,064 shares made by Harlan Baird Radford ,

In summary, during the past 3 months, insiders sold 0 shares of Allakos Inc (ALLK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 87,064 shares of Allakos Inc (ALLK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 87,064 shares.

Allakos Inc (ALLK)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Allakos Inc Insider Transactions

No Available Data

Alta Partners Viii, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Alta Partners Viii, L.p.. You might contact Alta Partners Viii, L.p. via mailing address: Po Box 7414, Jackson Wy 83002.